The Latest Cardiac and Vascular News
TORONTO–(BUSINESS WIRE)–Conavi Medical Inc. (www.conavi.com), a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand the presence of its Novasight Hybrid System in the U.S. market in 2022 under the guidance of its new leadership team. Thomas Looby, chief executive officer, Conavi Medical, appointed in […]
The Bluhm Family Foundation gift further expands access to world class cardiovascular care throughout the Chicagoland area CHICAGO, Feb. 14, 2022 /PRNewswire/ — Chicago philanthropist Neil G. Bluhm and the Bluhm Family Charitable Foundation announced a $45 million gift to establish the Northwestern Medicine Bluhm Heart Hospital at Northwestern Memorial Hospital. The gift expands cardiac care capacity and addresses […]
SUNNYVALE, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP™ Cell Therapy Heart […]
The Visible Heart Laboratories utilize Stratasys 3D printing technology for student and physician education as well as medical device research EDEN PRAIRIE, Minn. & REHOVOT, Israel–(BUSINESS WIRE)–Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing solutions, today announced that it is sponsoring the University of Minnesota Visible Heart® Laboratories with a donation […]
NAARDEN, Netherlands–(BUSINESS WIRE)–NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases, today announced the publication of a new review article in the European Society of Cardiology (ESC) publication Cardiovascular Research examining cholesteryl ester transfer protein (CETP) inhibition as a potentially high-impact therapeutic target for reducing […]
MALVERN, PA & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that the Phase 2b trial of bentracimab, which was conducted in healthy, older volunteers 50-80 years old, has been accepted for presentation in […]
Front Line Medical Technologies Article for CardiacVascular News Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as an adjunct for Patients Arriving in Cardiac Arrest to the Emergency Room Out-of-hospital cardiac arrest (OHCA) continues to be overwhelmingly fatal despite improvements in Advanced Cardiovascular Life Support (ACLS) protocols and increasing access […]
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) refinements and three new high-value tools. These updates come in […]
First of its kind service combines a specialized, multidisciplinary clinical care team with an AI-enabled care management platform for automated medication management, earlier interventions and improved outcomes BOSTON, Feb. 9, 2022 /PRNewswire/ — Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today the launch of Biofourmis Care, a first of […]
Malmö, Sweden, February 9, 2022 Acarix submits breakthrough designation request with FDA for heart failure diagnosis Acarix expands its portfolio and submits a breakthrough designation request for its innovative technology for heart failure diagnosis with the Food and Drug Administration (FDA) in USA. Heart failure affects more than 6 million people in the USA at […]
